Vassilis Nikolopoulos
Chief Executive Officer at Intelen, Inc.
Network origin in Vassilis Nikolopoulos first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University Of Dundee
9
| College/University | Other Consumer Services | 9 |
Intelen, Inc.
 Intelen, Inc. Packaged SoftwareTechnology Services Intelen, Inc. provides business and people with tools that transform real-time energy data into information. It has developed the Intelen DiG Engagement Platform which identifies with precision where and how energy is consumed. The company was founded in 2011 and is headquartered in Athlens, Greece.
1
| Private Company | Packaged Software | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Vassilis Nikolopoulos via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Private Equity Investor | |
| ABBVIE INC. | Pharmaceuticals: Major | Director/Board Member | |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Lyric Pharmaceuticals, Inc.
 Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Imperial College London | College/University | Doctorate Degree | |
| The University of Manchester | College/University | Corporate Officer/Principal | |
RiverVest Venture Management LLC
 RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | Investment Managers | Private Equity Investor | |
| Shanghai Federation Of Industry & Commerce | Corporate Officer/Principal | ||
| Heriot-Watt University | College/University | Doctorate Degree | |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Xiamen University | College/University | Undergraduate Degree | |
| King Saud University | College/University | Undergraduate Degree | |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder | |
| University of Missouri-Kansas City | College/University | Graduate Degree | |
| KNOWLEDGE ECONOMIC CITY COMPANY | Real Estate Development | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Chief Tech/Sci/R&D Officer | |
Mendeley Ltd.
 Mendeley Ltd. Packaged SoftwareTechnology Services Mendeley Ltd. develops social software for managing and sharing research papers. It is academic software for research paper management for academics and researchers. The company was founded by Victor Henning, Jan Reichelt and Paul Föckler in 2007 and is headquartered in London, the United Kingdom. | Packaged Software | Corporate Officer/Principal | |
| All-China Youth Federation | Corporate Officer/Principal | ||
Elastagen Pty Ltd.
 Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Medical Specialties | Director of Finance/CFO | |
| China Real Estate Chamber of Commerce | Director/Board Member | ||
| China Urban Realty Association | Corporate Officer/Principal | ||
| Shanghai Youth Federation | Corporate Officer/Principal | ||
OneVentures Management Pty Ltd.
 OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia. | Investment Managers | Private Equity Investor | |
| Rosy Fortune Investment Ltd. | Director/Board Member | ||
| Rain-Mountain Ltd. | Director/Board Member | ||
| Rady School of Management at UC San Diego | College/University | Masters Business Admin | |
| MEDICALSYSTEM BIOTECHNOLOGY CO., LTD | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Pembroke College Oxford | College/University | Graduate Degree | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder | |
247 Information Technology (Beijing) Co., Ltd.
 247 Information Technology (Beijing) Co., Ltd. Advertising/Marketing ServicesCommercial Services 247 Information Technology Beijing Co. Ltd. provides mobile technology services. It offers novel visual effects, proposal designs, and media efficient services. The company was founded by Benjamin Zhang, Lu Gao Hu, and Hao Ding in March 2013 and is headquartered in Beijing, China. | Advertising/Marketing Services | Chief Executive Officer | |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
Cellular Therapeutics Ltd.
 Cellular Therapeutics Ltd. BiotechnologyHealth Technology Part of Instil Bio, Inc., Cellular Therapeutics Ltd. is a British company that manufactures cell therapy products. The company is based in Manchester, UK. The company was founded by David Gilham. | Biotechnology | Founder | |
| MUSHARAKA REIT FUND | Investment Trusts/Mutual Funds | Director/Board Member | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| EVER SUNSHINE SERVICES GROUP LIMITED | Real Estate Development | Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
Sparrow Pharmaceuticals, Inc.
 Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sparrow Pharmaceuticals, Inc. engages in pharmaceuticals industry. It develops drugs for cushing?s syndrome. The company was founded by David A. Katz and is headquartered in Portland, OR. | Pharmaceuticals: Major | Director/Board Member | |
| Arab Open University | College/University | Corporate Officer/Principal | |
Alkaid Acquisition Corp.
 Alkaid Acquisition Corp. Financial ConglomeratesFinance Alkaid Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on March 11, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer | |
| You Bao Network Technology Shanghai Co., Ltd. | Chief Executive Officer | ||
| Chi Yan Business Consulting Shanghai Co., Ltd. | Chairman | ||
| 247Collective Ltd. | Director/Board Member | ||
| Shanghai Di Mai Culture Communication Co., Ltd., | Chief Executive Officer | ||
| China Payment Services Ltd. | Director/Board Member | ||
| UShow Ltd. | Director/Board Member |
Statistics
International
| United States | 18 |
| China | 13 |
| United Kingdom | 12 |
| Saudi Arabia | 5 |
| Australia | 3 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 10 |
| Finance | 7 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 25 |
| Corporate Officer/Principal | 12 |
| Doctorate Degree | 7 |
| Undergraduate Degree | 7 |
| Chief Executive Officer | 7 |
Most connected contacts
- Stock Market
- Insiders
- Vassilis Nikolopoulos
- Company connections
